News

Late-breaking data demonstrating the sustained improvements was presented at the American Academy of Dermatology Annual Meeting.

Dermatology Times recently spoke with Latanya Benjamin, MD, FAAD, FAAP, the newly-appointed president of the WDS, to discuss her hopes and goals for her presidency.

Two posters at the AAD Annual Meeting examined disparities in skin cancer survival between urban and rural areas and assessed how having skin of color affects this.

The recommendations were recently published in JAMA Dermatology following an extensive literature review, article grading, and a review of research questions.

The statement said the petition came as a surprise to many ahead of AAD, and delves into the data complexity and patient considerations.

We take a look at various studies examining the role of artificial intelligence in telemedicine photo quality, the impact of the COVID-19 pandemic and skin cancer diagnoses, and more.

In this week’s Pointers With Portela, the 208SkinDoc dives into the efficacy and adverse effects of generic vitamin A to treat acne.

While additional, larger studies are necessary, researchers said dietary choices may help reduce dependency on pharmacological methods.

We spoke with several dermatology experts to gauge their thoughts on Valisure's recent findings of benzene in benzoyl peroxide products--as well as what actions they plan to take moving forward.

In her March edition of Cosmetic Conundrums, Zoe Diana Draelos, MD, explores the role of exosomes in aesthetic dermatology, changes in the skin, and more.

We take a look at various studies exploring the relationship between psoriasis and COVID-19 vaccination, the link between COVID-19 and psoriasis severity, and more.

AI mobile apps have critical gaps in efficacy, safety, and transparency, according to a new report.

Den, the chief medical officer of Alpha Tau, discusses the alpha particle-emitting atom treatment and its ability to target cancer cells without harming healthy tissue.

The expanded approval of Spevigo follows the Chinese National Medical Products Administration’s approval for the injection for the reduction of occurrence of GPP.

The FDA has assigned a Prescription Drug User Fee Act target action date for August 13.

The social and psychological effects of vitiligo, particularly concerning gender disparities, have come to the forefront in recent literature.

Two recent studies delve into outcomes of pediatric populations with atopic conditions and an overview of patient outcomes utilizing a Mendelian randomization analysis.

On March 6, 2024, Valisure, an independent testing laboratory, found high levels of benzene when BPO products were incubated at 37°C, 50°C, and 70°C.

From our March cover feature: Vulnerable populations such as the prison population should have access to Mohs surgery to prevent the increased risk of morbidity and mortality from skin cancer.

The anticipated PDUFA date is November 4, 2024.

It has been 4 years since the COVID-19 pandemic began. In the time since, there has been plentiful research regarding its implications in dermatology.

The data suggests that the medication, which targets specific cellular pathways, promotes hair regrowth in AA with minimal adverse effects.

Keep up with the latest headlines in dermatology from the past week, including the AAD's vote to protect diversity, equity, and inclusion programs, a UK company's effort to democratize dermatologists’ services, and more.

ICYMI, this week we had news about AAD sessions and late-breaking research, the establishment of the very first annual National Dermatologist Day, benzene updates, and more.

This week’s collection of the latest dermatologic studies covers the relationship between vitamin D receptor expression and cutaneous melanoma outcomes, efficacy of intravenous immunoglobulin in adults with treatment-resistant eosinophilic fasciitis, high dose oral isotretinoin versus low dose for cutaneous and genital warts, and the loss of integrity in the dermal-epidermal junction and hemidesmosomes during skin aging.

The data was presented in a scientific session at the American Academy of Dermatology annual meeting.

With 30 years of clinical dermatology research under her belt, Draelos responds to recent benzene and BPO news in this Q&A.

A panel of experts discusses tailoring treatment to patient needs, supporting patients' mental health, and considering future directions.

Tween skin care has become a rising trend across social media platforms such as TikTok, and dermatology clinicians are becoming increasingly concerned about misinformation.

Following Valisure’s Citizen’s Petition to the US Food and Drug Administration, we are recapping recent years of regulatory action regarding benzene and carbomers.